|
|
|
Volumn 9, Issue SUPPL. 1, 2011, Pages 14-19
|
|
Opportunities in regenerative medicine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALIPOGENE TIPARVOVEC;
BIOMATERIAL;
CALCIUM PHOSPHATE;
CHONDROCYTE IMPLANT;
COLLAGEN;
SITIMAGENE CERADENOVEC;
TISSUE SCAFFOLD;
ALLOGENEIC STEM CELL TRANSPLANTATION;
ANUS FISTULA;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BREAST SURGERY;
CARTILAGE TRANSPLANTATION;
CELL REGENERATION;
CELL THERAPY;
CONSENSUS;
DIABETIC SKIN ULCER;
DNA MODIFICATION;
DRUG INDUSTRY;
EVIDENCE BASED MEDICINE;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
GENETIC ENGINEERING;
GENOMICS;
GOVERNMENT;
HEALTH CARE INDUSTRY;
HERNIOPLASTY;
HUMAN;
HYPERLIPOPROTEINEMIA TYPE 1;
IMMUNOTHERAPY;
INVESTMENT;
KNEE ARTHROPLASTY;
MOLECULAR THERAPY;
OPHTHALMOLOGY;
ORTHOPEDICS;
PANCREAS ISLET TRANSPLANTATION;
PERIPHERAL NERVE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PHASE 4 CLINICAL TRIAL (TOPIC);
REGENERATIVE MEDICINE;
SHORT SURVEY;
SKIN GRAFT;
SKIN ULCER;
STEM CELL TRANSPLANTATION;
TISSUE ENGINEERING;
UNITED STATES;
WOUND HEALING;
XENOTRANSPLANTATION;
|
|
EID: 79953050015
PISSN: 15426319
EISSN: None
Source Type: Trade Journal
DOI: None Document Type: Short Survey |
|
Times cited : (9)
|
|
References (2)
|
